ARMMS-T2D study alliance continues to show benefits of MBS over medical interventions for those with T2DMThe 12-year Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) clinical trial continues to...
US Task Force recommends intensive, comprehensive behavioural interventions for children and teens with a high BMIThe US Preventive Services Task Force (Task Force) has posted a final recommendation statement on interventions for high body mass index...
ARMMS-T2D study alliance continues to show benefits of MBS over medical interventions for those with T2DM
Journal Watch 3/07/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Lab values predict periprosthetic joint infection in patients living with severe obesityFor patients with severe obesity undergoing knee or hip replacement, commonly obtained laboratory values - including markers of anaemia...
GSA publishes recommendations for the successful care of older adults with obesityA summit convened by the Gerontological Society of America (GSA) has resulted in the identification of seven strategies for successful...
US Task Force recommends intensive, comprehensive behavioural interventions for children and teens with a high BMIThe US Preventive Services Task Force (Task Force) has posted a final recommendation statement on interventions for high body mass index...
OAC welcomes House Committee decision for advancing the Treat and Reduce Obesity Act The Obesity Action Coalition (OAC) has welcomed the House Ways and Means Committee for favourably reporting an amended version of the...
First patient dosed NeuroBo Pharmaceuticals’ Phase 1 clinical trial evaluating DA-1726 for the treatment of obesityNeuroBo Pharmaceuticals has dosed the first patient in the multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726,...
Vogenx announces positive results from second phase 2 study of mizagliflozin in post-bariatric hypoglycaemiaVogenx has announced positive results from study VGX 001-012 evaluating mizagliflozin in patients diagnosed with post-bariatric...
Specific gut bacteria are involved in compulsive eating and obesityAn international team of researchers has identified specific bacteria in the gut that are associated with both mice and humans developing...
The role of patient outcomes in driving business success for bariatric clinicsOver the last few years, the demand for bariatric services has grown steadily - as more people have become aware of the risks that are...
Xeno Biosciences initiate phase 1b proof-of-concept study for obesity drug candidate XEN-101Xeno Biosciences has initiated a Phase 1b clinical study designed to provide proof-of-concept weight loss results, along with safety and...
Specialist weight-loss services in England unable to keep up with spiralling demandOne in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as...
Journal Watch 26/06/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines